Home > News > Biophan CEO Addresses NanoBio Convergence Conference
October 27th, 2005
Biophan CEO Addresses NanoBio Convergence Conference
Abstract:
Biophan Technologies, Inc., a developer of next-generation medical technology, presented its proprietary nanotech-based solutions for drug delivery, vascular intervention and other global biomedical market segments at the NanoBioConvergence conference held yesterday in the San Francisco Bay Area.
Source:
businesswire
Bookmark:
Nanomedicine
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Announcements
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Energy
Polymer-coated catalyst protects "artificial leaf" June 17th, 2013
Efficient and inexpensive: Researchers develop catalyst material for fuel cells: Platinum-nickel nano-octahedra save 90 percent platinum June 17th, 2013
Nanoparticles helping to recover more oil June 15th, 2013
Nanoparticle Opens the Door to Clean-Energy Alternatives June 14th, 2013